BRKR Holds Stage 2 Uptrend in 4-Week Consolidation below 64.75 Pivot

Posted on by Eben@CANSLIM Research
BRKR stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 30, 2026 at 00:14 — CANSLIM Research
BRKR is trading at 62.26 in a Stage 2 advancing phase, holding above a rising 30-week moving average with a 7 of 8 trend template pass and price just 3.8 percent off its 52-week high. The market focus is on a four-week consolidation, 15.4 percent deep, that has not yet formed a complete base, with a 64.75 pivot as the level to watch for a breakout. Sentiment is bullish, reflecting an offensive setup, though the absence of a VCP contraction and a lagging relative strength line argue for patience until the pattern matures.

BRKR   Daily · data to 2026-10-29 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORHealthcareINDUSTRYMedical DevicesStage 2Weinstein stage
Intraday data, US market still open (as of Thu 29 Oct 12:14 ET)Created: Fri 30 Oct 00:14 HKT = 12:14 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of October 30, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts